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Pore progress: Oxford Nanopore’s modified 
nanopore can distinguish between the four 
standard DNA nucleotides and methylated 
cytosine. The aim is to use an endonuclease 
(green) to feed the nucleotides to the pore 
one by one. (Photo: iemedia solutions.)
Coming soon to a doctor’s surgery 
near you?
Hopes placed on the sequencing 
of ‘the’ human genome and the 
subsequent identification of many 
single-nucleotide polymorphisms 
(SNPs) have turned out to be 
misguided, as the causes of common 
diseases like cancer and heart disease 
have proven too complex to be 
addressed with simple SNP searches. 
Also, large-scale genomic differences 
like copy number variations (CNV) 
and insertions/deletions (indels) are 
now known to be equally important as 
SNPs, rendering the quest for genomic 
answers to medical problems ever 
more challenging. 
There is, however, the hope that 
large-scale analysis of individual 
genomes may yield some of the 
answers that SNPs failed to provide. 
And the rapid progress in sequencing 
technology, with the costs dropping 
more rapidly than those of computer 
technology (still following Moore’s 
Law), means that comparing 
thousands of individual genomes, 
thoughtfully chosen by epidemiological 
criteria, is now a perfectly viable 
approach to medical genomics.
At the more individual level, 
affordable genome analysis is also 
bound to aid diagnosis and therapy, 
especially in cancer. Soon it will be 
easy to compare the genome of a 
tumour with that of the patient’s 
healthy cells, enabling doctors to find 
out both what went wrong and what 
treatment is most likely to succeed. 
And this, when it happens, will be the 
real genome revolution.
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But isn’t NETosis just apoptosis 
by another name? Actually, no! 
These two processes are mediated 
by different pathways, with NETosis 
involving a distinct set of events. 
The primary difference between 
these two cell-death routines is the 
dramatic change that occurs in the 
nucleus of neutrophils committed 
to NET formation. The hallmark of 
the process is nuclear envelope 
breakdown, followed by expansion 
and decondensation of the chromatin. 
This is accompanied by release 
of anti-microbial proteins from 
neutrophil granules; these proteins 
subsequently mix with and adhere to 
the decondensed chromatin. The  
process culminates in rupture of the 
plasma membrane and, finally, release 
of a NET. In contrast, apoptosis 
involves DNA fragmentation and 
nuclear shrinkage, without breakdown 
of membranes. Similarly, in another 
cell-death process, necrosis, DNA 
remains enclosed in a nuclear 
envelope, although the typical 
lobulation of the neutrophil nucleus 
is lost. Despite similarities with these 
other pathways, NETosis is clearly a 
distinct process from other cell-death 
mechanisms.
How are NETs formed? The 
molecular details of NET formation 
have only recently begun to be 
unravelled. The phenomenon is 
tightly linked to the production 
of reactive oxygen species (ROS) 
by neutrophil NADPH oxidase. 
Accordingly, patients with mutations 
in this enzyme fail to make NETs and 
suffer from debilitating infections. 
In addition, individuals lacking 
myeloperoxidase, another key 
enzyme in the ROS cascade,  
are also unable to make NETs, thus 
providing further evidence for a role 
for ROS in NET formation. Although 
important, ROS are not the only 
crucial players in NET formation. 
During NETosis, decondensation  
of chromatin is also critical for 
proper NET formation. Recently, a 
role for neutrophil elastase  
in the decondensation process  
was demonstrated; this serine 
protease was shown to partially 
degrade histones. Histone  
cleavage presumably leads to 
relaxation and decondensation  
of chromatin and is thus a  
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What are neutrophil extracellular 
traps, or NETs? Neutrophils, the most 
abundant immune cells in humans, 
are the first line of defense against 
invading pathogens. They employ a 
wide array of anti-microbial strategies, 
most notably phagocytosis, to attack 
and eliminate pathogens. In 2004 a 
new and unexpected anti-microbial 
activity of neutrophils was uncovered: 
upon encountering bacteria, 
neutrophils release a mesh-like 
structure capable of ensnaring and 
eliminating microbes (Figure 1). These 
web-like traps contain a backbone 
consisting of DNA/histones and are 
peppered with anti-microbial peptides 
that normally reside within the 
neutrophil granules. These structures 
were dubbed NETs and the process of 
NET formation is known as NETosis.
What is the role of NETs 
in immunity? NETosis is an 
anti-microbial strategy that results in 
neutrophil death and contributes to 
pathogen control and elimination.  
In vitro, the microbicidal properties of 
NETs have been clearly demonstrated: 
they trap pathogens and prevent them 
from dispersing, while simultaneously 
destroying them through  
exposure to a high concentration of 
anti-microbial effectors. These  
anti-microbial effectors include, as 
expected, the anti-microbial proteins 
of the neutrophil granules. Perhaps 
unexpectedly, the histones in NETs 
are also key components of the anti-
microbial repertoire. It has long been 
known that histones are some of the 
most powerful anti-microbial agents 
that exist. Nevertheless, exactly how 
this anti-microbial activity of histones 
could be effectively harnessed was 
a long-standing and intractable 
mystery. The discovery of NETs 
presents a satisfying explanation 
for this apparent dilemma. Through 
NET formation, neutrophils provide 
histones with an opportunity to 
execute their alternative, non-
structural function: microbial killing.
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So are microbes totally helpless 
against NETs? Evolutionary 
pressure has produced creative 
and varied microbial strategies for 
avoiding immune system defenses, 
and NETs are no exception in this 
regard. Certain bacterial species, 
such as Streptococcus pneumoniae, 
contain capsule assembly genes  
that decrease binding to NETs.  
Some Streptococci secrete  
DNase, which has been shown to 
degrade NETs in vitro. Bacterial 
mutants that cannot secrete DNase 
are accordingly much less virulent 
in mouse models of infection. 
Speculation abounds that other 
bacterial species might inhibit  
NET formation altogether by 
preventing ROS formation. The 
existence of these microbial 
evolutionary adaptations  
against NETs further underscores a 
salient role for NETs during  
the innate immune response  
to infection.
NETs seem to be quite helpful — 
but do they have a dark side? 
As with all inflammatory responses, 
NETosis must be carefully regulated 
in order to prevent unwanted 
damage; failure to do so can have 
dire repercussions. Previous studies 
have shown that serum DNase I 
degrades NETs in the bloodstream. 
Disruption of this process leads to 
the generation of anti-self antibodies 
and can therefore contribute to 
the development of autoimmune 
diseases, such as systemic lupus 
erythematosus (SLE). The release 
of neutrophil contents into the 
extracellular space during NETosis 
raises several pertinent questions. 
How does the body go about 
cleaning up NETs? What happens 
when an individual produces too 
many NETs? Is the production of 
NETs in some cases more harmful 
than helpful? Such questions relating 
to the regulation and resolution of 
NET production are some of the 
most pressing issues in current NET 
research.
What can NETs teach us about the 
biology of the cell? NET formation 
is a unique (and fascinating!) 
immunological phenomenon, 
analysis of which might provide 
insight into biological principles 
such as cell death, regulation 
of chromatin structure, nuclear 
envelope disassembly and membrane 
dynamics. However, neutrophils are 
short-lived, terminally differentiated 
cells that are notoriously difficult 
to manipulate genetically; novel 
techniques will have to be developed 
to fully explore the process of 
NETosis. An understanding of NET 
formation is also contingent on a 
better understanding of how reactive 
oxygen serves as a signalling 
molecule. NADPH oxidase homologs 
are expressed by a variety of different 
tissues and the concept of ROS as 
signalling molecules is emerging 
as an important paradigm in cell 
signalling. Future studies on NET 
formation will, without a doubt, assist 
in deciphering the role of ROS in 
cell biology and continue to provide 
critical insights into the function of 
these unique signalling molecules.
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Figure 1. Scanning electron micrograph of Shigella flexneri trapped in a NET. The mesh-like 
structure of the NET is clearly visible between two still-intact neutrophils. Image courtesy of 
Volker Brinkmann.
